Undervalued Small Caps With Insider Buying

Results

56

10 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	UNB	US$23.62	-7.3%	-14.7%	US$114.4m	n/a	1.2	n/a	6.1%	Banks
	APPN	US$25.55	-1.8%	-16.7%	US$1.7b	US$26.20	2119.4	108.9%	n/a	Software
	SMWB	US$6.83	2.1%	-22.7%	US$551.0m	US$5.80	2.1	112.6%	n/a	Software
	BOTJ	US$27.01	1.1%	97.9%	US$122.4m	n/a	1.5	n/a	1.5%	Banks
	AOMR New	US$8.93	0.9%	-6.4%	US$219.2m	US$10.75	14.0	35.2%	14.3%	Diversified Financials
	FNLC	US$34.89	1.5%	34.1%	US$394.5m	n/a	1.3	n/a	4.4%	Banks
	SHBI	US$23.90	3.9%	47.6%	US$789.0m	US$25.00	1.3	9.2%	2.3%	Banks
	ANGX	US$4.37	-0.9%	-66.4%	US$755.0m	US$8.00	2.1	59.6%	n/a	Media
	MDV	US$17.67	-2.9%	21.8%	US$210.5m	US$18.67	1.1	149.5%	6.8%	Real Estate
	PAX	US$11.06	-0.3%	-19.3%	US$1.7b	US$15.57	24.3	34.3%	5.9%	Diversified Financials
	AUBN New	US$26.30	1.1%	-6.6%	US$93.0m	n/a	1.0	n/a	4.1%	Banks
	ILPT	US$9.01	5.0%	65.6%	US$613.3m	US$10.27	1.3	24.9%	2.2%	Real Estate
	ONT	US$19.86	0.3%	-14.7%	US$710.5m	US$27.00	162.2	98.9%	n/a	Commercial Services
	KINS	US$19.67	-2.5%	23.4%	US$288.4m	US$21.50	9.2	20.8%	1.0%	Insurance
	RCEL	US$4.75	-6.7%	-17.4%	US$146.2m	US$9.07	2.0	64.1%	n/a	Pharmaceuticals & Biotech
	PBHC New	US$16.00	-0.3%	7.1%	US$99.5m	n/a	0.8	n/a	2.5%	Banks
	UMH	US$15.52	-0.5%	-5.7%	US$1.3b	US$19.13	2.3	24.1%	5.8%	Real Estate
	FRST	US$15.80	-1.3%	35.4%	US$380.4m	US$18.13	0.9	-7.1%	2.5%	Banks
	MRBK	US$20.00	-1.3%	36.0%	US$235.7m	US$23.00	1.2	21.5%	2.8%	Banks
	CBAN New	US$21.74	4.1%	31.6%	US$463.5m	US$25.00	1.2	34.1%	2.2%	Banks
	KRO	US$6.13	-5.8%	0.5%	US$760.5m	US$6.50	0.4	5.9%	3.3%	Materials
	ANIK	US$15.02	-0.3%	32.6%	US$198.9m	US$17.50	1.7	67.6%	n/a	Pharmaceuticals & Biotech
	EMYB	US$22.50	-0.2%	39.8%	US$167.0m	n/a	1.3	n/a	2.1%	Banks
	BY	US$38.68	2.1%	41.3%	US$1.7b	US$41.00	1.3	0.5%	1.4%	Banks

Page 1 of 2